Nair, Asha <br/><br/>
Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain.  [electronic resource] 

 -  Molecular pain  Aug 2010 
 - 48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-8069 
<br/><br/><label>Standard No.: </label>10.1186/1744-8069-6-48  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Agatoxins<br/>Amino Acid Substitution--genetics<br/>Animals<br/>Calcineurin--metabolism<br/>Calcium Channels, N-Type<br/>Calcium Channels, P-Type--genetics<br/>Calcium Channels, Q-Type--genetics<br/>Calcium Signaling--drug effects<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 2--metabolism<br/>Enzyme Activation--drug effects<br/>Ganglia, Sensory--drug effects<br/>Gene Knock-In Techniques<br/>Intracellular Space--drug effects<br/>Ion Channel Gating--drug effects<br/>Membrane Potentials--drug effects<br/>Mice<br/>Migraine with Aura--complications<br/>Mutant Proteins--metabolism<br/>Mutation--genetics<br/>Pain--complications<br/>Phosphorylation--drug effects<br/>Phosphoserine--metabolism<br/>Potassium--metabolism<br/>Receptors, Purinergic P2X3--metabolism<br/>Sensory Receptor Cells--drug effects<br/>Spider Venoms--pharmacology<br/>Trigeminal Nerve--drug effects